Today, Diabetes is a common, serious, expensive, growing and
probably an inescapable public health issue. According to a publication by the
“National Center for Chronic Disease Prevention and Health Promotion”, around
135 million people in 1995 were diagnosed with diabetes and the number would
grow up to 300 million by the end of 2025. Furthermore, many risk factors are
associated with the aforesaid disease such as dietary problems, obesity,
insulin resistance and more health issues. Several health officials believe
diabetes can be avoided in the high -risk category, but people are yet to
observe the results of several clinical trials that are pending.
Meanwhile many glucose monitoring systems, the most
affordably acceptable technology are undergoing a face lift worldwide. These
medical devices can lower the burden of complications by early detection of
diabetes. Device manufacturers are now ready to catch -up with an accurate data
for continuous glucose monitoring through their inventions. In 2015, under the
sensors category Dexcom became one of its kind to provide continuous glucose
monitoring data from the “Apple Watch”. Product's G4 PLATINUM system needs
users to just pierce underneath their skin. Users then attaches a “Bluetooth
LTE” receiver that sends data to an “Apple Watch ". Some more popular
product choices in the sensors category today includes CIGMS by GlySure
Limited; Brian Otis's brainchild smart contact lens and Flash Glucose
Monitoring System from Abbott.
Similarly, government bodies too are giving a nod to severalmonitoring technologies for people with diabetes. In one such example in
January 2015 FDA had approved Dexcom mobile application for constant glucose
monitoring. In a similar incident FDA in US had backed the use of “Nova
StatStrip Glucose Hospital Meter System" for severely ill patient who were
hospitalized. This was the first time a BGMS was approved by FDA for such patients.
An article published in the “Diabetes Daily" indicates that the global
sales of test-strip as well as glucose meter supplies reach over 10 million
dollars each year. According to a report titled " Continuous Glucose
Monitoring Market " published by Allied Market Research the CGM market is
valued at $568.5 million is 2020. The report reveals that the aforementioned
market would see a CAGR of 14.8 percent during the forecast period of 2012 to
2020.
